What Happened after the Clinical Trials: Long-Term Safety and Efficacy of Ustekinumab in Daily Clinical Practice

Publisher： Karger

E-ISSN： 1421-9832|229|4|324-332

ISSN： 1018-8665

Source： Dermatology, Vol.229, Iss.4, 2014-11, pp. : 324-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Efficacy, Safety and Drug Survival of Ustekinumab in a Spanish Cohort of Patients with Moderate to Severe Plaque Psoriasis

By  

Dermatology, Vol. 230, Iss. 1, 2015-01 ,pp. : 46-54

Karger

Access to resources Recommend Favorite

The Impact of Methodological Approaches for Presenting Long-Term Clinical Data on Estimates of Efficacy in Psoriasis Illustrated by Three-Year Treatment Data on Infliximab

By  

Dermatology, Vol. 221, Iss. 1, 2010-08 ,pp. : 43-47

Karger

Access to resources Recommend Favorite

Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis

By  

Dermatology, Vol. 208, Iss. 4, 2004-06 ,pp. : 365-372

Karger

Access to resources Recommend Favorite

Prospective Randomized Long-Term Study on the Efficacy and Safety of UV-Free Blue Light for Treating Mild Psoriasis Vulgaris

By  

Dermatology, Vol. 231, Iss. 1, 2015-06 ,pp. : 24-34

Karger

Access to resources Recommend Favorite

A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis

By  

Dermatology, Vol. 217, Iss. 4, 2008-09 ,pp. : 321-328

Karger

Access to resources Recommend Favorite